Chapter/Section Purchase

1 Study Coverage
1.1 Recombinant Protein Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Protein Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Recombinant DNA
1.2.3 Recombinant RNA
1.3 Market by Application
1.3.1 Global Recombinant Protein Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Industry
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Protein Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Recombinant Protein Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Recombinant Protein Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Recombinant Protein Drugs Sales by Region
2.4.1 Global Recombinant Protein Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Recombinant Protein Drugs by Region (2023-2028)
2.5 Global Recombinant Protein Drugs Revenue by Region
2.5.1 Global Recombinant Protein Drugs Revenue by Region (2017-2022)
2.5.2 Global Recombinant Protein Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Recombinant Protein Drugs Sales by Manufacturers
3.1.1 Global Top Recombinant Protein Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Recombinant Protein Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant Protein Drugs in 2021
3.2 Global Recombinant Protein Drugs Revenue by Manufacturers
3.2.1 Global Recombinant Protein Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Recombinant Protein Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant Protein Drugs Revenue in 2021
3.3 Global Recombinant Protein Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Recombinant Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Recombinant Protein Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant Protein Drugs Sales by Type
4.1.1 Global Recombinant Protein Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Recombinant Protein Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Recombinant Protein Drugs Sales Market Share by Type (2017-2028)
4.2 Global Recombinant Protein Drugs Revenue by Type
4.2.1 Global Recombinant Protein Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Recombinant Protein Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Recombinant Protein Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Recombinant Protein Drugs Price by Type
4.3.1 Global Recombinant Protein Drugs Price by Type (2017-2022)
4.3.2 Global Recombinant Protein Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Recombinant Protein Drugs Sales by Application
5.1.1 Global Recombinant Protein Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Recombinant Protein Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Recombinant Protein Drugs Sales Market Share by Application (2017-2028)
5.2 Global Recombinant Protein Drugs Revenue by Application
5.2.1 Global Recombinant Protein Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Recombinant Protein Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Recombinant Protein Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Recombinant Protein Drugs Price by Application
5.3.1 Global Recombinant Protein Drugs Price by Application (2017-2022)
5.3.2 Global Recombinant Protein Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Recombinant Protein Drugs Market Size by Type
6.1.1 North America Recombinant Protein Drugs Sales by Type (2017-2028)
6.1.2 North America Recombinant Protein Drugs Revenue by Type (2017-2028)
6.2 North America Recombinant Protein Drugs Market Size by Application
6.2.1 North America Recombinant Protein Drugs Sales by Application (2017-2028)
6.2.2 North America Recombinant Protein Drugs Revenue by Application (2017-2028)
6.3 North America Recombinant Protein Drugs Market Size by Country
6.3.1 North America Recombinant Protein Drugs Sales by Country (2017-2028)
6.3.2 North America Recombinant Protein Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Recombinant Protein Drugs Market Size by Type
7.1.1 Europe Recombinant Protein Drugs Sales by Type (2017-2028)
7.1.2 Europe Recombinant Protein Drugs Revenue by Type (2017-2028)
7.2 Europe Recombinant Protein Drugs Market Size by Application
7.2.1 Europe Recombinant Protein Drugs Sales by Application (2017-2028)
7.2.2 Europe Recombinant Protein Drugs Revenue by Application (2017-2028)
7.3 Europe Recombinant Protein Drugs Market Size by Country
7.3.1 Europe Recombinant Protein Drugs Sales by Country (2017-2028)
7.3.2 Europe Recombinant Protein Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Recombinant Protein Drugs Market Size by Type
8.1.1 Asia Pacific Recombinant Protein Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Recombinant Protein Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Recombinant Protein Drugs Market Size by Application
8.2.1 Asia Pacific Recombinant Protein Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Recombinant Protein Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Recombinant Protein Drugs Market Size by Region
8.3.1 Asia Pacific Recombinant Protein Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Recombinant Protein Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Recombinant Protein Drugs Market Size by Type
9.1.1 Latin America Recombinant Protein Drugs Sales by Type (2017-2028)
9.1.2 Latin America Recombinant Protein Drugs Revenue by Type (2017-2028)
9.2 Latin America Recombinant Protein Drugs Market Size by Application
9.2.1 Latin America Recombinant Protein Drugs Sales by Application (2017-2028)
9.2.2 Latin America Recombinant Protein Drugs Revenue by Application (2017-2028)
9.3 Latin America Recombinant Protein Drugs Market Size by Country
9.3.1 Latin America Recombinant Protein Drugs Sales by Country (2017-2028)
9.3.2 Latin America Recombinant Protein Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Recombinant Protein Drugs Market Size by Type
10.1.1 Middle East and Africa Recombinant Protein Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Recombinant Protein Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Recombinant Protein Drugs Market Size by Application
10.2.1 Middle East and Africa Recombinant Protein Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Recombinant Protein Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Recombinant Protein Drugs Market Size by Country
10.3.1 Middle East and Africa Recombinant Protein Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Recombinant Protein Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novo Nordisk Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Merck Serono
11.5.1 Merck Serono Corporation Information
11.5.2 Merck Serono Overview
11.5.3 Merck Serono Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Serono Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Serono Recent Developments
11.6 Ortho Biotech
11.6.1 Ortho Biotech Corporation Information
11.6.2 Ortho Biotech Overview
11.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ortho Biotech Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ortho Biotech Recent Developments
11.7 Roche
11.7.1 Roche Corporation Information
11.7.2 Roche Overview
11.7.3 Roche Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Roche Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Roche Recent Developments
11.8 Kyowa Hakko Kirin
11.8.1 Kyowa Hakko Kirin Corporation Information
11.8.2 Kyowa Hakko Kirin Overview
11.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Kyowa Hakko Kirin Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kyowa Hakko Kirin Recent Developments
11.9 Pharmingen
11.9.1 Pharmingen Corporation Information
11.9.2 Pharmingen Overview
11.9.3 Pharmingen Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Pharmingen Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Pharmingen Recent Developments
11.10 Abcam
11.10.1 Abcam Corporation Information
11.10.2 Abcam Overview
11.10.3 Abcam Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Abcam Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abcam Recent Developments
11.11 GenSci
11.11.1 GenSci Corporation Information
11.11.2 GenSci Overview
11.11.3 GenSci Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GenSci Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GenSci Recent Developments
11.12 SL PHARM
11.12.1 SL PHARM Corporation Information
11.12.2 SL PHARM Overview
11.12.3 SL PHARM Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 SL PHARM Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 SL PHARM Recent Developments
11.13 Dongbao Pharm
11.13.1 Dongbao Pharm Corporation Information
11.13.2 Dongbao Pharm Overview
11.13.3 Dongbao Pharm Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Dongbao Pharm Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Dongbao Pharm Recent Developments
11.14 Ankebio
11.14.1 Ankebio Corporation Information
11.14.2 Ankebio Overview
11.14.3 Ankebio Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Ankebio Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ankebio Recent Developments
11.15 NCPC
11.15.1 NCPC Corporation Information
11.15.2 NCPC Overview
11.15.3 NCPC Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 NCPC Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 NCPC Recent Developments
11.16 Heng Rui
11.16.1 Heng Rui Corporation Information
11.16.2 Heng Rui Overview
11.16.3 Heng Rui Recombinant Protein Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Heng Rui Recombinant Protein Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Heng Rui Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant Protein Drugs Industry Chain Analysis
12.2 Recombinant Protein Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant Protein Drugs Production Mode & Process
12.4 Recombinant Protein Drugs Sales and Marketing
12.4.1 Recombinant Protein Drugs Sales Channels
12.4.2 Recombinant Protein Drugs Distributors
12.5 Recombinant Protein Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Recombinant Protein Drugs Industry Trends
13.2 Recombinant Protein Drugs Market Drivers
13.3 Recombinant Protein Drugs Market Challenges
13.4 Recombinant Protein Drugs Market Restraints
14 Key Findings in The Global Recombinant Protein Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer